- Zacks•27 days agoPharma Stock Roundup: Pfizer, Allergan Q3 Results Fall Short, Insulin Drugmakers under Pricing Pressure
Both Pfizer (PFE) and Allergan fell short of expectations while reporting Q3 earnings results. Meanwhile, the industry remains under drug pricing pressure.
- The Wall Street Journal•last month
Astellas Pharma Inc. has agreed to acquire venture-backed Ganymed Pharmaceuticals AG for €422 million ($463.5 million) plus potential milestone payments of up to another €860 million.
ALPMF : Summary for ASTELLAS PHARMA NPV - Yahoo Finance
Astellas Pharma, Inc. (ALPMF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.45|
|Dividend & Yield||0.33 (2.32%)|
|1y Target Est||N/A|